Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...
Start-up accelerators are designed to rapidly scale early-stage companies through mentorship, funding and resources.
The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...
Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...
Holmes was first seen with Evans at Burning Man festival in 2018, per the New York Times. Evans is graduate of the Massachusetts Institute of Technology. His father, Bill Evans, owns and operates ...
MUSCAT: IDO Investments, the tech investment arm of Oman Investment Authority (OIA), is among a number of leading ...
COEP Venture Group aims to identify, invest in, and support high-potential startups shaping the future of automation, intelligent systems, and AI-driven enterprise solutions. By providing capital, ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results